A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 18+
Code: NCT07661966
Recruiting
New
Mobile Sun Health Intervention EnabLing Daily Protection
for
Skin Cancer
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 18 - 29
Code: NCT07830394
Recruiting
New
A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
for
Nasal Polyps
Location: Plano TX
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07782957
Phase3, Recruiting
New
This Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of [18F]AV-133 Imaging Using High and Standard Resolution PET in Individuals Enrolled With Parkinson's Disease (PD) for up to 12 Months.
for
Parkinson's Disease (PD), Healthy Control Subjects
Location: New Haven CT
Sponsor: Michael J. Fox Foundation for Parkinson's Research
Sex: All
Age: 18+
Code: NCT07830654
Phase2, Recruiting
Active & ResponsiveNew
Remote Monitoring Using a Digital Platform
for
Chronic Pain
Location: Hackensack NJ, Paramus NJ
Sponsor: Hackensack Meridian Health
Sex: All
Age: 18+
Code: NCT07837102
Recruiting
Active & ResponsiveNew
Ancillary Nocturnal Urinary Symptoms Analyses for TRIUMPH
for
Nocturia
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: Female
Age: 60+
Code: NCT07829029
Recruiting
New
A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer
for
Colorectal Cancer (Locally Advanced or Metastatic)